Copyright Reports & Markets. All rights reserved.

Global Systemic Corticosteroids Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Systemic Corticosteroids Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Methylprednisolone
    • 1.3.3 Prednisolone
    • 1.3.4 Betamethasone
    • 1.3.5 Dexamethasone
    • 1.3.6 Prednisone
    • 1.3.7 Triamcinolone Acetonide
    • 1.3.8 Hydrocortisone
    • 1.3.9 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Systemic Corticosteroids Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Pharmacy
    • 1.4.4 Other
  • 1.5 Global Systemic Corticosteroids Market Size & Forecast
    • 1.5.1 Global Systemic Corticosteroids Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Systemic Corticosteroids Sales Quantity (2021-2032)
    • 1.5.3 Global Systemic Corticosteroids Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Systemic Corticosteroids Product and Services
    • 2.1.4 Pfizer Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Sandoz
    • 2.2.1 Sandoz Details
    • 2.2.2 Sandoz Major Business
    • 2.2.3 Sandoz Systemic Corticosteroids Product and Services
    • 2.2.4 Sandoz Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sandoz Recent Developments/Updates
  • 2.3 Hikma Pharmaceuticals
    • 2.3.1 Hikma Pharmaceuticals Details
    • 2.3.2 Hikma Pharmaceuticals Major Business
    • 2.3.3 Hikma Pharmaceuticals Systemic Corticosteroids Product and Services
    • 2.3.4 Hikma Pharmaceuticals Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 2.4 Teva Pharmaceutical
    • 2.4.1 Teva Pharmaceutical Details
    • 2.4.2 Teva Pharmaceutical Major Business
    • 2.4.3 Teva Pharmaceutical Systemic Corticosteroids Product and Services
    • 2.4.4 Teva Pharmaceutical Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.5 Lupin
    • 2.5.1 Lupin Details
    • 2.5.2 Lupin Major Business
    • 2.5.3 Lupin Systemic Corticosteroids Product and Services
    • 2.5.4 Lupin Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Lupin Recent Developments/Updates
  • 2.6 Zydus Pharmaceuticals
    • 2.6.1 Zydus Pharmaceuticals Details
    • 2.6.2 Zydus Pharmaceuticals Major Business
    • 2.6.3 Zydus Pharmaceuticals Systemic Corticosteroids Product and Services
    • 2.6.4 Zydus Pharmaceuticals Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Zydus Pharmaceuticals Recent Developments/Updates
  • 2.7 Sinopharm Group Rongsheng Pharmaceutical
    • 2.7.1 Sinopharm Group Rongsheng Pharmaceutical Details
    • 2.7.2 Sinopharm Group Rongsheng Pharmaceutical Major Business
    • 2.7.3 Sinopharm Group Rongsheng Pharmaceutical Systemic Corticosteroids Product and Services
    • 2.7.4 Sinopharm Group Rongsheng Pharmaceutical Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sinopharm Group Rongsheng Pharmaceutical Recent Developments/Updates
  • 2.8 Tianjin Tianyao Pharmaceuticals
    • 2.8.1 Tianjin Tianyao Pharmaceuticals Details
    • 2.8.2 Tianjin Tianyao Pharmaceuticals Major Business
    • 2.8.3 Tianjin Tianyao Pharmaceuticals Systemic Corticosteroids Product and Services
    • 2.8.4 Tianjin Tianyao Pharmaceuticals Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
  • 2.9 Liaoning Haisco Pharmaceutical
    • 2.9.1 Liaoning Haisco Pharmaceutical Details
    • 2.9.2 Liaoning Haisco Pharmaceutical Major Business
    • 2.9.3 Liaoning Haisco Pharmaceutical Systemic Corticosteroids Product and Services
    • 2.9.4 Liaoning Haisco Pharmaceutical Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Liaoning Haisco Pharmaceutical Recent Developments/Updates
  • 2.10 Nang Kuang Pharmaceutical
    • 2.10.1 Nang Kuang Pharmaceutical Details
    • 2.10.2 Nang Kuang Pharmaceutical Major Business
    • 2.10.3 Nang Kuang Pharmaceutical Systemic Corticosteroids Product and Services
    • 2.10.4 Nang Kuang Pharmaceutical Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Nang Kuang Pharmaceutical Recent Developments/Updates
  • 2.11 Chongqing Huapont Pharmaceutical
    • 2.11.1 Chongqing Huapont Pharmaceutical Details
    • 2.11.2 Chongqing Huapont Pharmaceutical Major Business
    • 2.11.3 Chongqing Huapont Pharmaceutical Systemic Corticosteroids Product and Services
    • 2.11.4 Chongqing Huapont Pharmaceutical Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
  • 2.12 Zhejiang Xianju Pharmaceutical
    • 2.12.1 Zhejiang Xianju Pharmaceutical Details
    • 2.12.2 Zhejiang Xianju Pharmaceutical Major Business
    • 2.12.3 Zhejiang Xianju Pharmaceutical Systemic Corticosteroids Product and Services
    • 2.12.4 Zhejiang Xianju Pharmaceutical Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
  • 2.13 Fuan Pharmaceutical
    • 2.13.1 Fuan Pharmaceutical Details
    • 2.13.2 Fuan Pharmaceutical Major Business
    • 2.13.3 Fuan Pharmaceutical Systemic Corticosteroids Product and Services
    • 2.13.4 Fuan Pharmaceutical Systemic Corticosteroids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Fuan Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Systemic Corticosteroids by Manufacturer

  • 3.1 Global Systemic Corticosteroids Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Systemic Corticosteroids Revenue by Manufacturer (2021-2026)
  • 3.3 Global Systemic Corticosteroids Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Systemic Corticosteroids by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Systemic Corticosteroids Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Systemic Corticosteroids Manufacturer Market Share in 2025
  • 3.5 Systemic Corticosteroids Market: Overall Company Footprint Analysis
    • 3.5.1 Systemic Corticosteroids Market: Region Footprint
    • 3.5.2 Systemic Corticosteroids Market: Company Product Type Footprint
    • 3.5.3 Systemic Corticosteroids Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Systemic Corticosteroids Market Size by Region
    • 4.1.1 Global Systemic Corticosteroids Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Systemic Corticosteroids Consumption Value by Region (2021-2032)
    • 4.1.3 Global Systemic Corticosteroids Average Price by Region (2021-2032)
  • 4.2 North America Systemic Corticosteroids Consumption Value (2021-2032)
  • 4.3 Europe Systemic Corticosteroids Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Systemic Corticosteroids Consumption Value (2021-2032)
  • 4.5 South America Systemic Corticosteroids Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Systemic Corticosteroids Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Systemic Corticosteroids Sales Quantity by Type (2021-2032)
  • 5.2 Global Systemic Corticosteroids Consumption Value by Type (2021-2032)
  • 5.3 Global Systemic Corticosteroids Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Systemic Corticosteroids Sales Quantity by Application (2021-2032)
  • 6.2 Global Systemic Corticosteroids Consumption Value by Application (2021-2032)
  • 6.3 Global Systemic Corticosteroids Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Systemic Corticosteroids Sales Quantity by Type (2021-2032)
  • 7.2 North America Systemic Corticosteroids Sales Quantity by Application (2021-2032)
  • 7.3 North America Systemic Corticosteroids Market Size by Country
    • 7.3.1 North America Systemic Corticosteroids Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Systemic Corticosteroids Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Systemic Corticosteroids Sales Quantity by Type (2021-2032)
  • 8.2 Europe Systemic Corticosteroids Sales Quantity by Application (2021-2032)
  • 8.3 Europe Systemic Corticosteroids Market Size by Country
    • 8.3.1 Europe Systemic Corticosteroids Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Systemic Corticosteroids Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Systemic Corticosteroids Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Systemic Corticosteroids Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Systemic Corticosteroids Market Size by Region
    • 9.3.1 Asia-Pacific Systemic Corticosteroids Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Systemic Corticosteroids Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Systemic Corticosteroids Sales Quantity by Type (2021-2032)
  • 10.2 South America Systemic Corticosteroids Sales Quantity by Application (2021-2032)
  • 10.3 South America Systemic Corticosteroids Market Size by Country
    • 10.3.1 South America Systemic Corticosteroids Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Systemic Corticosteroids Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Systemic Corticosteroids Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Systemic Corticosteroids Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Systemic Corticosteroids Market Size by Country
    • 11.3.1 Middle East & Africa Systemic Corticosteroids Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Systemic Corticosteroids Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Systemic Corticosteroids Market Drivers
  • 12.2 Systemic Corticosteroids Market Restraints
  • 12.3 Systemic Corticosteroids Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Systemic Corticosteroids and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Systemic Corticosteroids
  • 13.3 Systemic Corticosteroids Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Systemic Corticosteroids Typical Distributors
  • 14.3 Systemic Corticosteroids Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Systemic Corticosteroids market size was valued at US$ 21090 million in 2025 and is forecast to a readjusted size of US$ 36620 million by 2032 with a CAGR of 8.3% during review period.
    Systemic corticosteroids are medications that contain synthetic versions of the hormones produced by the adrenal glands. They are used to treat a variety of medical conditions, including autoimmune disorders, asthma, allergies, and skin conditions such as eczema and psoriasis.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Systemic Corticosteroids market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Systemic Corticosteroids market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Systemic Corticosteroids market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Systemic Corticosteroids market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Systemic Corticosteroids market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Systemic Corticosteroids
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Systemic Corticosteroids market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Sandoz, Hikma Pharmaceuticals, Teva Pharmaceutical, Lupin, Zydus Pharmaceuticals, Sinopharm Group Rongsheng Pharmaceutical, Tianjin Tianyao Pharmaceuticals, Liaoning Haisco Pharmaceutical, Nang Kuang Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Systemic Corticosteroids market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Methylprednisolone
    Prednisolone
    Betamethasone
    Dexamethasone
    Prednisone
    Triamcinolone Acetonide
    Hydrocortisone
    Other
    Market segment by Application
    Hospital
    Pharmacy
    Other
    Major players covered
    Pfizer
    Sandoz
    Hikma Pharmaceuticals
    Teva Pharmaceutical
    Lupin
    Zydus Pharmaceuticals
    Sinopharm Group Rongsheng Pharmaceutical
    Tianjin Tianyao Pharmaceuticals
    Liaoning Haisco Pharmaceutical
    Nang Kuang Pharmaceutical
    Chongqing Huapont Pharmaceutical
    Zhejiang Xianju Pharmaceutical
    Fuan Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Systemic Corticosteroids product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Systemic Corticosteroids, with price, sales quantity, revenue, and global market share of Systemic Corticosteroids from 2021 to 2026.
    Chapter 3, the Systemic Corticosteroids competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Systemic Corticosteroids breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Systemic Corticosteroids market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Systemic Corticosteroids.
    Chapter 14 and 15, to describe Systemic Corticosteroids sales channel, distributors, customers, research findings and conclusion.

    Buy now